Yantai Dongcheng Pharmaceutical Co Ltd (002675) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Yantai Dongcheng Pharmaceutical Co Ltd (002675) has a cash flow conversion efficiency ratio of 0.042x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥239.54 Million ≈ $35.05 Million USD) by net assets (CN¥5.66 Billion ≈ $827.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Yantai Dongcheng Pharmaceutical Co Ltd defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Yantai Dongcheng Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)
This chart illustrates how Yantai Dongcheng Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Yantai Dongcheng Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yantai Dongcheng Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
|
0.008x |
|
Qisda Corp
TW:2352
|
-0.072x |
|
Devyani International Limited
NSE:DEVYANI
|
0.095x |
|
Minera Valparaiso S.A.
SN:MINERA
|
0.026x |
|
Beijing Lier High Temperature Materials Co Ltd
SHE:002392
|
0.010x |
|
Healthcare Services Group Inc
NASDAQ:HCSG
|
0.085x |
|
DOMS Industries Limited
NSE:DOMS
|
0.046x |
|
Domain Holdings Australia Limited
F:3DH
|
0.011x |
Annual Cash Flow Conversion Efficiency for Yantai Dongcheng Pharmaceutical Co Ltd (2008–2025)
The table below shows the annual cash flow conversion efficiency of Yantai Dongcheng Pharmaceutical Co Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see 002675 company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥5.66 Billion ≈ $827.65 Million |
CN¥584.61 Million ≈ $85.55 Million |
0.103x | +93.35% |
| 2024-12-31 | CN¥5.37 Billion ≈ $786.01 Million |
CN¥287.15 Million ≈ $42.02 Million |
0.053x | +4.15% |
| 2023-12-31 | CN¥5.40 Billion ≈ $789.55 Million |
CN¥276.94 Million ≈ $40.53 Million |
0.051x | -72.79% |
| 2022-12-31 | CN¥5.28 Billion ≈ $772.97 Million |
CN¥996.54 Million ≈ $145.82 Million |
0.189x | +0.44% |
| 2021-12-31 | CN¥5.02 Billion ≈ $735.14 Million |
CN¥943.58 Million ≈ $138.08 Million |
0.188x | +62.89% |
| 2020-12-31 | CN¥4.97 Billion ≈ $726.63 Million |
CN¥572.58 Million ≈ $83.79 Million |
0.115x | -20.87% |
| 2019-12-31 | CN¥4.78 Billion ≈ $699.31 Million |
CN¥696.38 Million ≈ $101.90 Million |
0.146x | +36.26% |
| 2018-12-31 | CN¥4.61 Billion ≈ $674.68 Million |
CN¥493.06 Million ≈ $72.15 Million |
0.107x | +68.33% |
| 2017-12-31 | CN¥3.29 Billion ≈ $481.25 Million |
CN¥208.94 Million ≈ $30.57 Million |
0.064x | -0.18% |
| 2016-12-31 | CN¥3.08 Billion ≈ $451.28 Million |
CN¥196.28 Million ≈ $28.72 Million |
0.064x | +113.39% |
| 2015-12-31 | CN¥2.24 Billion ≈ $327.19 Million |
CN¥66.69 Million ≈ $9.76 Million |
0.030x | -32.08% |
| 2014-12-31 | CN¥1.18 Billion ≈ $173.30 Million |
CN¥52.00 Million ≈ $7.61 Million |
0.044x | +334.72% |
| 2013-12-31 | CN¥1.10 Billion ≈ $161.16 Million |
CN¥-20.60 Million ≈ $-3.01 Million |
-0.019x | -142.66% |
| 2012-12-31 | CN¥1.02 Billion ≈ $148.60 Million |
CN¥44.53 Million ≈ $6.52 Million |
0.044x | -90.38% |
| 2011-12-31 | CN¥304.42 Million ≈ $44.55 Million |
CN¥138.83 Million ≈ $20.31 Million |
0.456x | +52.81% |
| 2010-12-31 | CN¥191.06 Million ≈ $27.96 Million |
CN¥57.02 Million ≈ $8.34 Million |
0.298x | +257.54% |
| 2009-12-31 | CN¥140.43 Million ≈ $20.55 Million |
CN¥-26.60 Million ≈ $-3.89 Million |
-0.189x | -136.16% |
| 2008-12-31 | CN¥79.34 Million ≈ $11.61 Million |
CN¥41.57 Million ≈ $6.08 Million |
0.524x | -- |
About Yantai Dongcheng Pharmaceutical Co Ltd
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. engages in the raw materials, formulations, nuclear medicine, and big health businesses in China and internationally. It operates through API, Formulation, Radio Pharmaceutical, and Others segments. The company offers formulation products, such as powder injections, tablets, capsules, granules, and drop pills for anticoagulation, cardiovascular, anti… Read more